Related Experiment Video
Updated: Jun 20, 2026

Temporal Analysis of the Nuclear-to-cytoplasmic Translocation of a Herpes Simplex Virus 1 Protein by Immunofluorescent Confocal Microscopy
Published on: November 4, 2018
Herpesvirus protein ICP27 switches PML isoform by altering mRNA splicing
Takayuki Nojima1, Takako Oshiro-Ideue, Hiroto Nakanoya
1Department of Functional Genomics, Laboratory of Gene Expression, School of Biomedical Science, Tokyo Medical and Dental University, Tokyo.
Abstract:
Viruses use alternative splicing to produce a broad series of proteins from small genomes by utilizing the cellular splicing machinery. Since viruses use cellular RNA binding proteins for viral RNA processing, it is presumable that the splicing of cellular pre-mRNAs is affected by viral infection. Here, we showed that herpes simplex virus type 2 (HSV-2) modifies the expression of promyelocytic leukemia (PML) isoforms by altering pre-mRNA splicing. Using a newly developed virus-sensitive splicing reporter, we identified the viral protein ICP27 as an alternative splicing regulator of PML isoforms. ICP27 was found to bind preferentially to PML pre-mRNA and directly inhibit the removal of PML intron 7a in vitro. Moreover, we demonstrated that ICP27 functions as a splicing silencer at the 3' splice site of the PML intron 7a. The switching of PML isoform from PML-II to PML-V as induced by ICP27 affected HSV-2 replication, suggesting that the viral protein modulates the splicing code of cellular pre-mRNA(s) governing virus propagation.
Insights
Herpes simplex virus type 2 (HSV-2) alters cellular pre-mRNA splicing. The viral protein ICP27 acts as a splicing silencer, modifying promyelocytic leukemia (PML) isoform expression and impacting HSV-2 replication.
Area of Science:
- Molecular Biology
- Virology
- Genetics
Background:
- Viruses leverage host cell machinery, including alternative splicing, to expand their proteomic output from limited genomes.
- Viral infections can disrupt host cell processes, potentially affecting cellular pre-messenger RNA (pre-mRNA) splicing due to interactions with cellular RNA-binding proteins.
Purpose of the Study:
- To investigate how herpes simplex virus type 2 (HSV-2) infection influences the splicing of cellular pre-mRNAs.
- To identify specific viral proteins involved in regulating alternative splicing of cellular genes.
- To elucidate the mechanism by which viral proteins modulate host cell splicing patterns.
Main Methods:
- Development and utilization of a novel virus-sensitive splicing reporter system.
- Identification of viral protein ICP27 as a key regulator of promyelocytic leukemia (PML) isoform splicing.
- In vitro binding assays to demonstrate ICP27's preferential binding to PML pre-mRNA.
- Functional analysis of ICP27's role as a splicing silencer at a specific intronic splice site.
Main Results:
- HSV-2 infection was shown to alter the expression of promyelocytic leukemia (PML) isoforms through modifications in pre-mRNA splicing.
- The viral protein ICP27 was identified as a direct regulator of PML alternative splicing.
- ICP27 was observed to bind preferentially to PML pre-mRNA and inhibit the removal of intron 7a.
- ICP27 functions as a splicing silencer at the 3' splice site of PML intron 7a, leading to a switch from PML-II to PML-V isoforms.
- This ICP27-induced shift in PML isoforms was found to affect HSV-2 replication.
Conclusions:
- Herpes simplex virus type 2 ICP27 directly modulates host cell pre-mRNA splicing, specifically targeting PML isoforms.
- ICP27 acts as a splicing silencer, altering the cellular splicing code to favor specific PML isoforms.
- The observed changes in PML isoform expression by ICP27 play a role in regulating HSV-2 viral propagation.
Related Concept Videos
RNA Splicing
Leaky Scanning
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
